Patents by Inventor Yoav Blatt
Yoav Blatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230225368Abstract: An in-feed life cycle interruption agent (LCIA) including a granulated core comprising LCIA material and a coating on the core. Related methods and products are also disclosed. Examples of LCIA include, but are not limited to Naturally occurring insect toxins (NOIT such as saponin and Insect Growth Regulators (IFR) such as Cyromazine.Type: ApplicationFiled: August 2, 2021Publication date: July 20, 2023Applicant: BERGMAN INDUSTRIES LTDInventors: Anat Hoyzman, Yoav Blatt, Ashgan Beshara, Elisheva Ohana, Shimon Elmaliah, Udi Reiss
-
Patent number: 10993982Abstract: The present invention provides a therapeutic composition comprising heat-treated clear tomato concentrate (CTC), which has been found to possess both anti-inflammatory and bone-health promoting effects. The present invention is also directed to a composition comprising heat-treated CTC in combination with one or more carotenoids.Type: GrantFiled: January 22, 2014Date of Patent: May 4, 2021Assignee: LYCORED LTD.Inventors: Tatyana Atlasman, Yoav Blatt, Rachel Levy, Yoav Sharoni, Joseph Levy, Morris Zelkha
-
Publication number: 20150352169Abstract: The present invention provides a therapeutic composition comprising heat-treated clear tomato concentrate (CTC), which has been found to possess both anti-inflammatory and bone-health promoting effects. The present invention is also directed to a composition comprising heat-treated CTC in combination with one or more carotenoids.Type: ApplicationFiled: January 22, 2014Publication date: December 10, 2015Inventors: Tatyana ATLASMAN, Yoav BLATT, Rachel LEVY, Yoav SHARONI, Joseph LEVY, Morris ZELKHA
-
Patent number: 8460718Abstract: Pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a synergistic combination of lycopene and at least one phytosterol wherein the ratio of said lycopene to said phytosterol in said pharmaceutical composition is a maximum of about 5:1 and wherein said composition produces a synergistic inhibition of cell growth are disclosed.Type: GrantFiled: April 7, 2011Date of Patent: June 11, 2013Assignee: LycoRed Ltd.Inventors: Morris Zelkha, Yoav Blatt, Yossi Levy, Yoav Sharoni
-
Publication number: 20120258182Abstract: Pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a synergistic combination of lycopene and at least one phytosterol wherein the ratio of said lycopene to said phytosterol in said pharmaceutical composition is a maximum of about 5:1 and wherein said composition produces a synergistic inhibition of cell growth are disclosed.Type: ApplicationFiled: April 7, 2011Publication date: October 11, 2012Applicant: LycoRed Ltd.Inventors: Morris Zelkha, Yoav Blatt, Yossi Levy, Yoav Sharoni
-
Patent number: 7097868Abstract: A microencapsulated composition containing lipophilic compounds is prepared by reducing the particle size of the lipophilic compound in the presence of a surface active agent to form a first solution; preparing a solution of alkali metal alginate to form a second solution; combining the first and second solutions to form a third solution; adding the third solution dropwise to a fourth solution containing calcium ion, obtaining beadlets, and removing the formed beadlets from the fourth solution; rinsing the beadlets with an acidic solution and drying the beadlets; and coating the beadlets to obtain microcapsules.Type: GrantFiled: August 23, 2001Date of Patent: August 29, 2006Assignee: Bio-Dar Ltd.Inventors: Yoav Blatt, Rika Pinto, Oleg Safronchik, Tanya Sedlov, Morris Zelkha
-
Publication number: 20050106272Abstract: The present invention provides improved beadlet formulations useful for inclusion in dietary supplements customized for improving and maintaining ocular nutrition. In particular, the improved beadlets comprise DHA (docosahexaenoic acid); rosemary and/or its components; and excipients.Type: ApplicationFiled: March 28, 2003Publication date: May 19, 2005Inventors: John Lang, Yoav Blatt, Pavel Kazhdan, Rika Pinto, Oleg Safronchik
-
Patent number: 6890561Abstract: There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one granulated isoflavone-enriched fraction and at least one carrier, diluent or excipient therefor. Preferably, the formulation is characterized in that the total in vitro dissolution time of said formulation required for release of 75% of the active ingredients available from the formulation is between about 4 and about 18 hours, as determined by the U.S.P. XXIII paddle method at a paddle speed of 75 rpm, using simulated intestinal fluid without the digestive enzymes normally found in intestinal fluid, at pH 6.8, and a temperature of 37° C. A process for the preparation of such a formulation is also provided.Type: GrantFiled: August 15, 2000Date of Patent: May 10, 2005Assignee: Bio Dar Ltd.Inventors: Yoav Blatt, Oded Arad, Eugene Kimelman, David Cohen, Rika Pinto, Avner Rotman
-
Publication number: 20030064133Abstract: A microencapsulated composition containing lipophilic compounds is prepared by reducing the particle size of the lipophilic compound in the presence of a surface active agent to form a first solution; preparing a solution of alkali metal alginate to form a second solution; combining the first and second solutions to form a third solution; adding the third solution dropwise to a fourth solution containing calcium ion, obtaining beadlets, and removing the formed beadlets from the fourth solution; rinsing the beadlets with an acidic solution and drying the beadlets; and coating the beadlets to obtain microcapsules.Type: ApplicationFiled: August 23, 2001Publication date: April 3, 2003Applicant: Bio-Dar LtdInventors: Yoav Blatt, Rika Pinto, Oleg Safronchik, Tanya Sedlov, Morris Zelkha
-
Patent number: 6340478Abstract: There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated herb, comprising a granulated herb and at least one carrier, adjuvant or excipient therefor. Preferably, the formulation is characterized in that the total in vitro dissolution time of said formulation required for release of 75% of the active ingredients available from the formulation is between about 4 and about 18 hours, as determined by the U.S.P. XXIII paddle method at a paddle speed of 150 rpm, using simulated intestinal fluid without the digestive enzymes normally found in intestinal fluid, containing 0.1% w/w sodium dodecyl sulfate (SDS), at pH 6.8, and a temperature of 37° C. A process for the preparation of such formulation is also provided.Type: GrantFiled: June 7, 1999Date of Patent: January 22, 2002Assignee: Bio Dar Ltd.Inventors: Yoav Blatt, Eugene Kimmelman, David Cohen, Avner Rotman
-
Patent number: 6270803Abstract: There are provided orally-administrable formulations for the controlled release of granulated garlic, comprising particles of granulated garlic coated with a film comprising a mixture of at least one water soluble polymer and at least one water insoluble polymer, said at least one water soluble polymer and at least one water insoluble polymer being present in a ratio that produces a substantially zero order linear release pattern of at least one active ingredient. Preferably, the formulations are characterized in that the total in vitro dissolution time of said formulations required for release of 75% of the Allicin available from said formulations based upon the total amount of alliin initially present in said formulations is between about 4 and about 12 hours, as determined by U.S.P. XXIII paddle method at a paddle speed of 150 rpm, using simulated intestinal fluid without the digestive enzymes normally found in intestinal fluid, containing 0.1% w/w sodium dodecyl sulfate (SDS), at pH 6.Type: GrantFiled: October 7, 1998Date of Patent: August 7, 2001Assignee: Bio Dar Ltd.Inventors: Yoav Blatt, David Cohen, Eugene Kimmelman, Oded Friedman, Avner Rotman
-
Patent number: 6156347Abstract: The present invention relates to controlled/extended release oral dosage forms of chromium picolinate. Chromium picolinate is a common and effective biologically active form of chromium. As such, it has beneficial nutritional and therapeutic effects including improved insulin metabolism and lipid lowering activity.The controlled dosage form of the present invention can be provided in various ways, including matrix formulations such as matrix tablets or multiparticulate formulations like micro capsules or coated pellets put into hard gelatin capsules. This provides effective drug delivery for extended periods of time, at relatively stable, optimal plasma peak values, with minimal undesirable side effects.The invention provides effective controlled/extended release oral dosage formulations of chromium picolinate and processes for their preparation.Type: GrantFiled: January 21, 1998Date of Patent: December 5, 2000Assignee: Bio-Dar Ltd.Inventors: Yoav Blatt, Oded Friedman, Eugene Kimelman, Avner Rotman
-
Patent number: 5098725Abstract: Very small particles of flavoring materials which are labile when subjected to both heat and an aqueous medium are coated with a coating material containing hydrogenated castor oil and having a melting point of from about 80.degree. to about 100.degree. C. The coating layer remains stable during the first minutes of the baking process, when the concentration of water in the dough or batter is relatively high. After several minutes, when most of the water in the dough or batter has evaporated and the temperature increases to about 100.degree. C., the coating layer or layers melt away. Within a few minutes thereafter, the active ingredient is exposed within the product. Alternatively, a leavening agent may be used wihtin the capsule which will release a gas at the predetermined temperature and cause rupture of the microencapsulation.Type: GrantFiled: March 29, 1990Date of Patent: March 24, 1992Assignee: Bio-Dar, Ltd.Inventors: Avner Rotman, Yoav Blatt